20
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Rhizome essential oil of Curcuma zedoaroides Chaveer. & Tanee: chemical composition, cytotoxic activities, and molecular docking approach

, , , , , , , & show all
Pages 188-197 | Received 01 Nov 2022, Accepted 29 Jan 2024, Published online: 15 Feb 2024
 

Abstract

Curcuma zedoaroides Chaveer. & Tanee (Vietnamese name: Nghệ đắng) belongs to the Zingiberaceae family which is the new Curcuma species discovered in Thailand and Vietnam in recent years. This study aimed to determine the chemical compositions and the cytotoxic activities of C. zedoaroides rhizome essential oil for the first time. The essential oil was obtained from the rhizomes through hydro-distillation and analyzed by gas chromatography-mass spectrometry (GC-MS) technique. Results showed that the majority of the rhizome essential oil of C. zedoaroides was dominated by oxygenated sesquiterpenes (61.54%) mainly curdione (27.45%), followed by widdrol (8.03%) and trans-β-elemenone (5.47%). Notably, the essential oil of C. zedoaroides rhizomes exhibited cytotoxic activities using the MTT assay with the IC50 (half-maximal effective concentration) values of 75.16 ± 2.79, 77.08 ± 1.98, 81.35 ± 1.55, 83.67 ± 2.26, 32.74 ± 1.95, 23.14 ± 1.43, 73.35 ± 2.20 μg/mL against A549, MCF-7, HepG2, HT29, HL-60, K562 and MDA-MB-231 cells, respectively. In addition, three major compounds targeting specific proteins related to essential oil’s anti-cancer activity were assessed using molecular docking simulation. From the results observed, widdrol was suggested to have the highest binding affinity for both EGFR and HER2, with ΔG values of -6.246 kcal/mol and -6.916 kcal/ mol, respectively. These results suggest the potential of the rhizome essential oil of C. zedoaroides to provide leads for the development of anti-cancer agents as well as considered a valuable source of bioactive components.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.